Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study
Objective To analyze the association of sleep duration and use of sleeping medication with multimorbidity. Materials and Methods We conducted a cross-sectional study using data from the Prospective Study about Mental and Physical Health (PAMPA) cohort. Multimorbidity was defined as the pr...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Revinter Publicações Ltda.
2023-03-01
|
Series: | Sleep Science |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1767757 |
_version_ | 1797368167543078912 |
---|---|
author | Felipe Mendes Delpino Eduardo L. Caputo Ricardo Alexandre Arcêncio Júlia Cassuriaga Caroline Malue Huckembeck Bruno Pereira Nunes Airton José Rombaldi Felipe Fossati Reichert Marcelo Cozzensa da Silva Natan Feter |
author_facet | Felipe Mendes Delpino Eduardo L. Caputo Ricardo Alexandre Arcêncio Júlia Cassuriaga Caroline Malue Huckembeck Bruno Pereira Nunes Airton José Rombaldi Felipe Fossati Reichert Marcelo Cozzensa da Silva Natan Feter |
author_sort | Felipe Mendes Delpino |
collection | DOAJ |
description | Objective To analyze the association of sleep duration and use of sleeping medication with multimorbidity.
Materials and Methods We conducted a cross-sectional study using data from the Prospective Study about Mental and Physical Health (PAMPA) cohort. Multimorbidity was defined as the presence of two or more conditions from a list of twelve health problems. Descriptive analyses were performed considering proportion and its 95% confidence interval (95%CI). We performed logistic regression (to obtain odds ratios, ORs) to estimate the associations, including models adjusted for confounding factors.
Results In total, 2,936 participants were included, 79,1% of them women, 54.2% aged between 18 and 39 years, and 88.9% with white skin color. Compared with regular sleep (seven to eight hours a day), five hours or less of sleep increased the odds of multimorbidity by 145% (95%CI: 1.90–3.14), and 9 hours or more of sleep increased the odds by 49% (95%CI: 1.14–1.95) for the crude model; the results remained significant even in the adjusted models.
Discussion Consumption of sleeping medication was associated with multimorbidity. Short and prolonged sleep duration increased the odds of multimorbidity, regardless of the sociodemographic and behavior characteristics. The regular use of sleeping medication was also associated with multimorbidity. The results of the present study are important but require caution due to reverse causality, and longitudinal studies are needed to confirm the findings. |
first_indexed | 2024-03-08T17:28:47Z |
format | Article |
id | doaj.art-7eb4610dd2884ac4a0a07400c3b65379 |
institution | Directory Open Access Journal |
issn | 1984-0659 1984-0063 |
language | English |
last_indexed | 2024-03-08T17:28:47Z |
publishDate | 2023-03-01 |
publisher | Thieme Revinter Publicações Ltda. |
record_format | Article |
series | Sleep Science |
spelling | doaj.art-7eb4610dd2884ac4a0a07400c3b653792024-01-02T17:21:57ZengThieme Revinter Publicações Ltda.Sleep Science1984-06591984-00632023-03-01160106807410.1055/s-0043-1767757Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort StudyFelipe Mendes Delpino0Eduardo L. Caputo1Ricardo Alexandre Arcêncio2Júlia Cassuriaga3Caroline Malue Huckembeck4Bruno Pereira Nunes5Airton José Rombaldi6Felipe Fossati Reichert7Marcelo Cozzensa da Silva8Natan Feter9Federal University of Pelotas, Postgraduate Program in Nursing, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilUniversity of São Paulo, Postgraduate Program in Nursing in Public Health, São Paulo, São Paulo, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Nursing, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilObjective To analyze the association of sleep duration and use of sleeping medication with multimorbidity. Materials and Methods We conducted a cross-sectional study using data from the Prospective Study about Mental and Physical Health (PAMPA) cohort. Multimorbidity was defined as the presence of two or more conditions from a list of twelve health problems. Descriptive analyses were performed considering proportion and its 95% confidence interval (95%CI). We performed logistic regression (to obtain odds ratios, ORs) to estimate the associations, including models adjusted for confounding factors. Results In total, 2,936 participants were included, 79,1% of them women, 54.2% aged between 18 and 39 years, and 88.9% with white skin color. Compared with regular sleep (seven to eight hours a day), five hours or less of sleep increased the odds of multimorbidity by 145% (95%CI: 1.90–3.14), and 9 hours or more of sleep increased the odds by 49% (95%CI: 1.14–1.95) for the crude model; the results remained significant even in the adjusted models. Discussion Consumption of sleeping medication was associated with multimorbidity. Short and prolonged sleep duration increased the odds of multimorbidity, regardless of the sociodemographic and behavior characteristics. The regular use of sleeping medication was also associated with multimorbidity. The results of the present study are important but require caution due to reverse causality, and longitudinal studies are needed to confirm the findings.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1767757diseasesmultimorbiditysleepsleep deprivation |
spellingShingle | Felipe Mendes Delpino Eduardo L. Caputo Ricardo Alexandre Arcêncio Júlia Cassuriaga Caroline Malue Huckembeck Bruno Pereira Nunes Airton José Rombaldi Felipe Fossati Reichert Marcelo Cozzensa da Silva Natan Feter Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study Sleep Science diseases multimorbidity sleep sleep deprivation |
title | Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study |
title_full | Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study |
title_fullStr | Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study |
title_full_unstemmed | Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study |
title_short | Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study |
title_sort | association of sleep duration and use of sleeping medication with multimorbidity in adults results from the pampa brazil cohort study |
topic | diseases multimorbidity sleep sleep deprivation |
url | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1767757 |
work_keys_str_mv | AT felipemendesdelpino associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy AT eduardolcaputo associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy AT ricardoalexandrearcencio associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy AT juliacassuriaga associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy AT carolinemaluehuckembeck associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy AT brunopereiranunes associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy AT airtonjoserombaldi associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy AT felipefossatireichert associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy AT marcelocozzensadasilva associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy AT natanfeter associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy |